Ianalumab Improved Clinical Response in Moderate-to-Severe SLE in Phase 2 Trial
A recent study published in Annals of the Rheumatic Diseases evaluated ianalumab (VAY736), a fully
Recommended Posts
Rituximab demonstrates significant real-world effectiveness and acceptable safety in Sjögren’s disease: Evidence from the PORTRESS registry
A recent study published in Clinical Rheumatology has reported that treatment with rituximab significantly reduced
Anifrolumab demonstrates rapid and sustained disease control in real-world systemic lupus erythematosus study
Targeted biologic therapies have significantly expanded the therapeutic landscape for systemic lupus erythematosus (SLE). Although
RA flares assessed by FLARE-RA questionnaire linked to disease activity measures but not structural damage progression
A recent prospective study published in Joint Bone Spine has provided important findings into the
Tight-control strategy with golimumab achieves high remission rates in early axial spondyloarthritis regardless of gut inflammation
A treat-to-target strategy incorporating early biologic escalation achieves high rates of sustained remission in treatment-naïve
Radiographic non-progression linked to greater low disease activity achievement in psoriatic arthritis patients on secukinumab
A recent post hoc analysis published in Rheumatology (Oxford) has shown that patients with psoriatic
Low-dose mepolizumab reduced steroid dependence and supported remission in refractory EGPA
A prospective cohort study published in the The Korean Journal of Internal Medicine reports that
Quiz Corner
Quiz for MRI in Rheumatology
February 5, 2022
First Round quiz on Scleritis
February 3, 2022
Quiz for Dry Eye and Rheumatology
January 21, 2022
Raynaud’s Phenomenon Quiz
January 20, 2022
Immunology and Inflammation
[Day-2]Virtual Bi-Monthly Lecture series – 5 on Immunology and Inflammation
Dr. Sampath Rangasamy spoke about the role of inflammation in microvascular diabetic complications.
February 7, 2022
No Comments
[Day-1]Virtual Bi-Monthly Lecture series – 5 on Immunology and Inflammation
Dr. K. Gokulakrishnan discussed the adipose tissue and brain – The neuroinflammatory link. Neuroinflammation
February 7, 2022
No Comments
Immune-Mechanism of Autoimmune related Inflammatory Diseases of Skin
Dr. Chandrashekara. S discussed the Immune-Mechanism of Autoimmune related Inflammatory Diseases of Skin. Skin
January 1, 2022
No Comments
Auto-immune mediated Inflammatory Skin Disorder – Introduction to Clinical Variety
Autoimmune-mediated inflammatory skin disorder- introduction to clinical variety was discussed by Dr. Shekhar Neema.
January 1, 2022
No Comments
[Day-2] Lecture Series 4 (Autoimmunity and Inflammation)
Dr. Jyotirmay Biswas spoke about autoimmune uveitis and scleritis. 50% and 90% of uveitis and
November 17, 2021
No Comments
Eye and Rheumatology Series
Eye and Rheumatology Series – 4 : Anterior Uveitis
Dr. Padmamalini discussed the clinical clues in the differential diagnosis of anterior uveitis.
March 3, 2022
No Comments
Eye and Rheumatology Series – Episcleritis and Scleritis
Clinical evaluation of episcleritis & scleritis and interpretation of the differential diagnosis of episcleritis
February 1, 2022
No Comments
Eye and Rheumatology Series: Dry Eye Conditions
Dr. Prarthana Bhandary spoke about the ophthalmological perspective of dry eye differential diagnosis and
January 13, 2022
No Comments
Eye and Rheumatology Series : Ocular Surface Inflammation
Dr. Shilpa discussed briefly ocular surface inflammation including the different conditions i.e., Dry eye disease,
December 31, 2021
No Comments
Eye and Rheumatology Series – Interactive session
Rheumatology and Ophthalmology interactive series Inflammatory disease of the eye- Introduction Ocular surface inflammation- introduction
December 10, 2021
No Comments
Investigation in Rheumatology
February 7, 2022
No Comments
January 13, 2022
No Comments
You must be logged in to post a comment.